Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I am moving money around to buy more shares...looks like we could see .48 or .49 do to the inevatable Paulson fire sale and I don't want to miss those!
Also Dr. P got me excited in this last speech..talking about when Dr. Pestell approached cydy and told them they did not realize what they had..referring to the use of Pro 140 in cancer.
I liked the CC. Biggest plus's for me were the patent info. And the rapid pace put on using the prostate test to generate revenue.
You can patent cell receptor use for all cancers?... Seems odd but I am glad we have it.
Yes you are right...but are they reporting rumors?... Or making up the rumors in house?..
I have thought of going "all in" several times. But even though I believe this is a fantastic opportunity....i haven't gone "All in" on this conviction. Very few people really go all in..in anything..and if you are already quite rich I imagine it is even harder to go all in...it has more to do with fear than logic.
Isn't it a big deal that they put in PowerPoint that they are in negotiations with BP ?... At least I don't recall them doing that before... I like it.
I never get weary of hearing things like that! Thanks for the encouraging post!
I also added yesterday ( but at .59) and i also believe finacing will come from the Pestell side of things...he seemed to hint before that he could find a partner on the cancer studies. I think it was Bulldog88 who said that the countdown to finiancing began after the merger, and that also rings true.
When we get promising results TNBC in 3 months that should mean a partner in 2Q 2019?
Interesting article. If some researches Dr. Paolo P. Provenzano...I bet we can find out what exactly what cell pathways they are talking about in this article. I wont have time till this weekend.
If triple negative breast cancer has an overabundance of ccr5 receptors in play then they better use the 700mg or more in their trial. What do you feel about that? And is that question you can ask them?
I have a buy it at .55 again. So if you could sink the price down to there i would appriciate it.
I am expecting strong anti cancer metastasis numbers in a few months :)
Towards the end of the video Dr. Pestell says that Merck and Pfizer have opened ccr5 focused clinical cancer trials!!
Now I am sure that even those giant companies have heard of Pro 140. The list of ccr5 antagonist is short..the only that keeps showing up is maraviroc. And we already know Pro 140 is the better drug.
When you see numbers for cydy like down .0004 does that indicate algorythmic trading?
I dont remember seeing numbers like that a couple years ago.
I picked up some at .55...i figured it was a low ball bid... But it filled.
Lets conduct a study of 25 patients at 900mg...and go for 99-100 percent..lol
Those charts really make the progress clear!
Your DD...is off the chart. Thanks for it.
Very cool...great lyrics.
Yep..dvax was flying... Then the board decided to take the drug to market themselves and shareholders have been on a downhill run ever since.
So I think fine and amateur just wanted to say the cydy should not go it alone and take drug to market themselves...therefore BO.
Thanks for that!
I take it to mean... Cancer partner is a must have, and hopefully they want HIV and a prostate test.
Starting to feel like a Gillead competitor would have more to gain than Gillead themselves... Since gild would only be maintaining market share... so to speak.
I would also be unhappy with 5. Because it's giving the company away cheap...but we are equally giving away the company cheap to Paulson...
The science is crazy good... And I already know it stops cancer metastasis in its tracks or Dr. Pestell would not be here.
So we will always be giving the company away cheap regardless....
I see people saying it should be $2 a share right now. It cant happen, and if it did it would be very briefly.
Do you remember when Dr. P cancelled the GvHD? His reasoning was that he could raise money at higher prices in a couple months.
Maybe he was talking about showing results from the 700mg dose on HIV..or maybe he was talking about the merger..or maybe cancer results..or maybe he was talking about his solution to the naked shorts???
But either way he said RAISE money at higher SP...and we know that means Paulson...whom he calls a banker.. So that higher SP won't last even if it gets there.
Thanks for the link...what i heard was: if we dont get the price we want for cydy...we are going to use paulson until 2020 and then take the drug to market ourselves...
Terrifying interview. Lol...
The big numbers being thrown around also concerned me. It makes me think we are no where near a deal because no one is going to pay what we want to either buy or partner...i also get the feeling Nadar and Pestell dont feel motivated to sell.
I think going it alone is the worst possible decision for shareholders.
Otherwise great news on the science. I will probably buy more shares.
I will try this question another way. I picture a virus as this smart little weasel that changes..hides..and is basically impossible to get rid of...i picture cancer as the is dumb "blob" that just regenerates and grows. I am hoping pro 140 can more easily stop it than HIV.
Does cancer metastasis have as many tricks up its sleeve as a virus?
Question for you. In humansa, is blocking cancer by blocking the CCR5 receptor the exact same thing as blocking it for HIV?
Hiv uses a pair of co-receptors if I remember right from reading. Is there a chance that blocking cancer could be even easier than blocking a virus?
So the idea is that over time 98million shares have been added to the float illegally "and that don't even exist" by a MM in order to put selling pressure on the stock...and to drive the stock even lower they will have to create even more fake stock to keep the price from rising?
Are these shorts so patient? And they are willing to risk so much on a company that could partner or be bought out at any time?.. And with the risk of being caught doing something illegal? It sound beyond risky...it sounds insane.
So how do we use this info About naked shorts? How does cydy use this short info.? Or is the idea that ... now that this info is more public another group will come in..buy up shares..and force a short squeeze?
I don't understand this area of the market so any info is appreciated.
Thanks for the info. I don't like the sound of heavy dilution. I hope they have some funding plans to tell us about in the CC. Maybe they can talk me into buying more shares. Like they did last time. Lol
This is the big question: why hasnt BP jumped already?
I just go back to... Dr pestell jumped.
Yep.. 6 months or more. I was slighltly dissapointed in this news but we still have a great shot at income in 2019.
Gene editing has side effects for sure. Did you see this article?
https://www.scientificamerican.com/article/crispr-edited-cells-linked-to-cancer-risk-in-2-studies/
I wish I had played the ups and downs...and this one looked like a particularly obvious play, but I get very nervous selling in phase 3. But I am depositing more money into my account for the return of the .50 shares in order to lower my average and accumulate.
Pro 140 has no legit competition. All other ccr5 antagonists can rest in peace. We were voted best in class by the ccr5 expert himself Dr Pestell. Any company looking for a ccr5 antagonist will only be shopping in one place.
This is not an hiv drug.. This is a cell protection device that can be used for, who knows, how many health issues?
Can I hear an Amen!
Ok..I see what your saying.
I did not expect money and licencing deal that quick " as in at close of prostagene deal"....but that would be great! I was expecting revenue from licencing to be closer to mid to late 2019... And figured we would need raises in between now and then.
I agree...there will be more raises.
I did not even think about that....that cancer metastasis would be easier for pro 140 to stop than HIV .... Thanks for that!!
Couldn't Dr Pestell have taken his cancer screening tests to market himself and not shared all that revenue with CYDY?...I think so... And that alone would probably have been worth more than he got in shares right? Plus we got him and patents. Of course he got his pro 140 and he must have thought it was worth it!!Haha..it just looks like a very positive development that he was willing.
Thank you for the follow up on gvhd. I really need to listen to that CC again...hope to today..there was so much in there.
I am very excited that dilution may come to an end in 2019 when cancer screening tests pay off. I wish I could corner Dr Pestell and ask him over and over again why exactly he gave cydy such a good deal.... Was pro 140 that convincing in his tests!! Or does he have something else up his sleeve? He made a commitment to cydy for 3 years right?.. So they must figure that is more than enough time? I also get the feeling of something else out of left corner coming to bowl us over...something good. Anyone else get that vibe with Dr Pestell on board?
Nadar obviously likes him, that was very apparent.
The odds are that you are right. But why can't Nadar just say that?.. Why does he have to say the reason is dilution at low SP?.. Why can't he just say it was Burgers area...he is gone now..so we need time to put a guy on it.
It really seems manipulative for the CEO to give reasons for things that are not the truth...did I say manipulative?.. I meant an outright lie...if what you say is the case.
A few hours ago I started think something similar. It struck me as so strange that we would take a trial like gvhd, where we were batting a 1000, and then put it on hold with the reson that Nadar gave about dilution. Almost as if a BP asked nadar not to focus on that for now... Am I being so optimistic? Or maybe its as simple as get the prostagene deal done first...then go back to normal operations?
Sorry I mean prostagene.
Nadar says that they want to wait on gvhd until they can raise money at higher prices rather than dilute more now. He says a few months from now.
For the delays that people keep talking about the most important thing is going to come much faster than thought .. Revenue from the progenics deal through a licensing agreement. I will have to listen again ... Did anyone catch an estimated date on that?..